Dr. Nifong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 University Dr
Hershey, PA 17033Phone+1 800-233-4082
Education & Training
- Penn State Milton S Hershey Medical CenterResidency, Pathology-Anatomic and Clinical, 1997 - 2000
- Penn State Milton S Hershey Medical CenterResidency, Anesthesiology, 1996 - 1999
- Highland Hospital of RochesterInternship, Internal Medicine, 1995 - 1996
- University of Rochester School of Medicine and DentistryClass of 1995
Certifications & Licensure
- PA State Medical License 1999 - 2024
- MA State Medical License 2011 - 2018
- CA State Medical License 2013 - 2016
- FL State Medical License 2012 - 2016
- GA State Medical License 2013 - 2015
- American Board of Pathology Clinical Pathology
Publications & Presentations
PubMed
- 116 citationsDevelopment and Clinical Validation of an In Situ Biopsy-Based Multimarker Assay for Risk Stratification in Prostate CancerPeter Blume-Jensen, David M. Berman, David L. Rimm, Michail Shipitsin, Mathew Putzi
Clinical Cancer Research. 2015-03-02 - 101 citationsIdentification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling errorMichail Shipitsin, Catherine B. Small, Sibgat Choudhury, Eldar Giladi, S Friedlander
British Journal of Cancer. 2014-09-09 - 49 citationsAutomated quantitative multiplex immunofluorescence in situ imaging identifies phospho-S6 and phospho-PRAS40 as predictive protein biomarkers for prostate cancer letha...Michail Shipitsin, Clayton Small, Eldar Giladi, Summar Siddiqui, Sibgat Choudhury
Proteome Science. 2014-07-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: